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Abstract
Background: Multiple mechanisms have been advanced to account for CD4+FOXP3+ regulatory T cell (Treg)-mediated
suppression of CD4+ effector T cells (Teffs) but none appear to completely explain suppression. Previous data indicates that
Tregs may affect the microenvironment redox state. Given the inherent redox sensitivity of T cells, we tested the hypothesis
that oxidants may mediate the direct suppression of Teffs by Tregs.
Methodology/Principal Findings: Tregs and Teffs were isolated from the spleens of wild type (WT) C57BL/6 mice or
Ncf1(p47phox)-deficient C57BL/6 mice which lack NADPH oxidase function. Teffs were labeled with CFSE and co-cultured
with unlabeled Tregs at varying Treg:Teff ratios in the presence of anti-CD3/CD28 coated beads for 3 days in suppression
assays. Treg-mediated suppression was quantified by flow cytometric analysis of CFSE dilution in Teffs. The presence of the
antioxidants n-acetylcysteine (NAC) or 2-mercaptoethanol or inhibitors of NADPH oxidase (diphenyleneiodonium and VAS-
2870) resulted in reduced WT Treg-mediated suppression. The observed suppression was in part dependent upon TGFb as it
was partially blocked with neutralizing antibodies. The suppression of Teff proliferation induced by exogenous TGFb
treatment could be overcome with NAC. Ncf1-deficient Teff were slightly but significantly less sensitive than WT Teff to
suppression by exogenous TGFb. Ncf1-deficient Tregs suppressed Ncf1-deficient Teff very poorly compared to wild type
controls. There was partial but incomplete reconstitution of suppression in assays with WT Tregs and Ncf1-deficient Teff.
Conclusions/Significance: We present evidence that NADPH oxidase derived ROS plays a role in the direct Treg mediated
suppression of CD4+ effector T cells in a process that is blocked by thiol-containing antioxidants, NADPH oxidase inhibitors
or a lack of Ncf1 expression in Tregs and Teffs. Oxidants may represent a potential new target for therapeutic modulation of
Treg function.
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Introduction
Numerous factors have been reported to account for
CD4+FOXP3+ regulatory T cell (Treg)-mediated immune sup-
pression including those that are cytotoxic such as perforin and
granzyme B [1] and those that suppress proliferation and cytokine
secretion in target cells. The latter category includes factors such as
IL-10, TGFb and CTLA-4 and mechanisms such as suppression of
IL-2 production by target cells or Il-2 sequestration by Tregs [2].
Some of these mechanisms are active in in vitro suppression assays,
where Tregs and CD4+ target cells are co-cultured in the presence
of stimuli, whereas others have been identified primarily in in vivo
models. The ultimate contribution of any particular mode of
suppression in vivo is unclear butis the subject of widespread inquiry.
Overall, the existing data is somewhat contradictory but indicates
that there are multiple and likely-context dependent pathways
whereby Tregs suppress the activation of CD4+FOXP3- T effector
cells (Teffs). The existing literature indicates that this occurs by both
direct mechanisms, which can be measured in in vitro co-culture
assays, and by indirect mechanisms where Tregs modulate the
activity of dendritic cells and macrophages that, in turn, affect
suppression. The latter scenarios are likely best evaluated in in vivo
models.
One of the major suppressive factors employed by Tregs is
TGFb. TGFb is present primarily in a membrane bound form on
Tregs [3,4,5]. Neutralizing antibodies to TGFb block Treg-
mediated suppression of Teffs in vitro [4,5] and targeted deletion
of the TGFb receptor renders Teffs non responsive to Treg
mediated suppression in vivo [6]. In murine models with T cell
specific TGFb deletion, there is severe autoimmune disease that
results in death only 1–2 weeks after birth [7]. TGFb appears
particularlyimportant forthesuppression ofautoimmunecolitis [8].
The mechanism by which TGFb suppresses T cell activation
remains mostly unresolved but likely involves a variety of pathways
[9]. TGFb has numerous other functions as well. Together with IL-
2, it is important for the peripheral differentiation of suppressive,
inducedTregsthatalsoexpresstheTreg specifictranscriptionfactor
FOXP3 [10]. In non-immune cell types including hepatocytes and
myofibroblasts, TGFb appears to activate pathways that, at least in
part, act via upregulation of the prooxidant enzyme complex
NADPH oxidase [11,12,13]. In accordance with this, variouseffects
of TGFb may be suppressed by treatment with antioxidants such as
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TGFb -mediated epithelial-mesenchymal transition of alveolar
epithelial cells by NAC both in vivo and in vitro [15]. The possibility
that NAC modulates TGFb signaling in T cells has, to our
knowledge, not been investigated.
Cysteineis important for T cell proliferation and activationand is
a precursor to glutathione (GSH). Depletion of intracellular GSH
with L-buthionine sulfoximine (BSO), an inhibitor of GSH
synthesis, results in suppression of T cell proliferation [16]. T cells
are particularly sensitive to cysteine depletion in the extracellular
milieu as they are unable to take up cystine, the major extracellular
form. However, dendritic cells secrete cysteine and in this way
regulate the proliferative potential of local T cells by controlling
cysteine availability[17].Recentdata suggests that Tregsareable to
suppress the secretion of cysteine into the microenvironment by
dendritic cells to indirectly suppress Teff proliferation via cysteine
depletion [18]. Myeloid derived suppressor cells (MDSCs) also
deprive T cells of cysteine and thus appear to act in a similar fashion
[19]. Interestingly, T cells are also very sensitive to the levels of
reduced cell surface thiols, or the cell surface redox state, and their
proliferation and activation can be increased by increasing surface –
SH groups with NAC or glutathione [20]. Cellular redox balance
may be influenced by the activity of NADPH oxidase, a major
intracellular source of oxidants and a complex that is present in T
cells [21]. NADPH oxidase is comprised of multiple subunits, two of
which, Ncf1 (p47
phox) and NOX2 (gp91
phox), have been implicated
as necessary for sustained reactive oxygen species (ROS) production
in T cells [21]. ROS can be detected upon T cell receptor (TCR)
stimulation [22,23] and functions to suppress signaling effectors,
such as ERK [24]. Thus, in T cells ROS may, at least in certain
circumstances, act as a negative regulator of activation. The
possibility that Tregs directly induce oxidant stress in Teffs has not
widely investigated as a mechanism of suppression.
In light of these previous findings, we evaluated the role of ROS
in direct Treg-mediated suppression of Teffs using antioxidants,
NADPH oxidase inhibitors and T cells from Ncf1-deficient
(Ncf1
2/2) mice that lack a functional NADPH oxidase complex
due to a substitution mutation that results in aberrant Ncf1 gene
splicing. This mutation results in a lack of detectable Ncf1 protein
by western blotting and a lack of NADPH oxidase function [25].
Our studies showed that Treg suppression of Teffs was partially
dependent on TGFb and could be reduced or blocked by NAC, 2-
mercaptoethanol (2-ME) or inhibitors of NADPH oxidase
(diphenyleneiodonium [26] and VAS-2870 [27]). Furthermore,
experiments performed in Ncf1-deficient cells demonstrated an
essential role for a functional NADPH oxidase complex in both
Tregs and target Teffs for optimum suppression. These findings
suggest that oxidants mediate an unexplored pathway of direct
Treg-mediated suppression of Teffs. Furthermore, they suggest
that targeted antioxidant therapy may be clinically helpful in
modulating the suppressive activity of Tregs in vivo in circum-
stances, such as the tumor microenviroment, where blocking the
function of Tregs may be beneficial.
Materials and Methods
Ethics Statement
All experimental procedures were approved by the University of
Utah Institutional Animal Care and Use Committee (protocol
#08-07012).
Mice
The mutation that resulted in the Ncf1 (p47
phox)-deficient
mouse strain (B6(Cg)-Ncf1
m1J/J) arose spontaneously in C57BL/6
mice with Lepr mutations and has been described [25]. The
original Lepr mutations have been bred out by crossing onto wild
type C57BL/6 mice. This strain and wild type C57BL/6 mice
were both purchased from Jackson Laboratory (Bar Harbor, ME).
Mice were maintained in a pathogen free environment in
temperature-controlled conditions under a 12-hour light/dark
cycle. Animals were used in experiments at between 6 and 14
weeks of age.
Reagents and cell culture
RPMI 1640 medium (HyClone, Logan, UT) containing 10%
fetal calf serum (HyClone) was used for cell culture. Cultures were
maintained in a 37uC incubator containing 5% CO2. Beads
coated with anti-mouse CD3/CD28 were from Invitrogen
(Carlsbad, CA). Sterile, preservative-free n-acetylcysteine solution
(20%) was from American Regent (Shirley, NY). 2-mercaptoeth-
anol and dimethyl sulfoxide (DMSO) were from Sigma-Aldrich
(St. Louis, MO). Where indicated, recombinant human TGFb1
(R&D Systems, Minneapolis, MN) or anti-mouse TGFb1 blocking
antibodies (R&D Systems) were added to T cell cultures. L-
buthionine sulfoximine was from Sigma, the flavoprotein inhibitor
diphenyleneiodonium chloride and the NADPH oxidase inhibitor
VAS-2870 [27] were both from Enzo Life Sciences (Plymouth
Meeting, PA).
Flow cytometry
Flow cytometric immunophenotyping was performed on a 4-
color Accuri C6 flow cytometer (Accuri Inc, Ann Arbor, MI). Data
was analyzed using FCS Express software (De Novo Software, Los
Angeles, CA). Anti-mouse CD25-PE was from Miltenyi Biotec
(Auburn, CA), anti-mouse CD4-FITC (clone RM4-5) and anti-
mouse FOXP3-APC (clone FJK-16s) were both from eBioscience
(San Diego, CA). Permeabilization was performed using a FOXP3
fixation/permeabilization kit, also from eBioscience. Flow cyto-
metric sorting was performed on a FACSAria II sorter (BD
Biosciences, San Jose, CA).
T cell isolation
Spleens were removed from sacrificed mice and macerated then
strained with sterile cell strainers (BD Biosciences, Bedford, MA) to
create a single cell suspension. Red blood cells were subsequently
lysed with RBC lysis buffer (eBioscience). Samples were washed
and CD4+CD25+FOXP3+ Tregs were isolated based on their
surface expression of CD25 using a magnetic bead based isolation
kit (Miltenyi Biotec, Inc.) per the manufacturer’s instructions. The
CD4+CD25- fraction was used as Teff cells.
In vitro suppression assays
After isolation as above, a portion of the Treg and Teff samples
was subjected to flow cytometric evaluation for expression of CD4,
CD25 and FOXP3 prior to mixing for suppression assays. Because
a small percentage of CD4+CD25+ T cells are not Tregs and do
not express FOXP3, the isolated Treg samples were never
completely pure, based on FOXP3 expression, and ranged from
approximately 80%–85% FOXP3 positive. To ensure optimal
reproducibility of the suppression assays, the degree of purity of
the Treg samples was taken into account when the cells were
plated so that the final ratio of CD4+FOXP3+ Tregs to
CD4+FOXP3- Teff was as close as possible to 1:1, 1:2 or 2:1 as
indicated in the figures. The consistent and low percentage of
CD4- cells that co-purified with the CD4+ cells was not considered
in the final ratio. Prior to co-plating Tregs and Teffs, the
CD4+FOXP3- Teff cells were labeled with carboxyfluorescein
Regulatory T Cells and Ncf1
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1 mM CFSE in phosphate buffered saline at 37uC for 3.5 mins.
CFSE stock solutions were diluted in DMSO prior to use. Samples
were then placed in RPMI + 10% FCS and incubated on ice for
10 minutes then washed 2 times. Treg:Teff mixtures or control
samples consisting of Teffs alone were plated in RPMI + 10% FCS
in 96 well round bottom plates (Corning Life Sciences, Lowell,
MA) in triplicate. All wells contained an equal final number of
total CD4+ T cells. Anti mouse-CD3/CD28 coated beads
(Invitrogen) were added to a final ratio of 1 bead per cell. Samples
were then incubated in a 37uC incubator for 3 days. The
proliferation of CFSE labeled Teffs was subsequently evaluated by
a flow cytometric quantification of CFSE dilutional staining as
described [28]. Percent suppression was calculated using prolifer-
ation measurements and the following formula: suppression (%) =
(1 - Teffs in Treg:Teff/Teffs alone)6100. A general outline of the
suppression assay protocol is shown in Figure 1.
Quantitative RT-PCR analysis of Ncf1, Ncf2 and gp91
phox
expression
C57BL/6 mouse CD4+CD25- T cells were purified by flow
cytometric sorting (.98% pure) then stimulated with CD3/CD28
beads +/2 TGFb (10 ng/mL) for one or two days as indicated.
Total RNA was isolated from samples using the RNeasy mini kit
(Qiagen Inc, Germantown, MD) per the manufacturer’s instruc-
tions. The levels of mRNA for Ncf1, Ncf2, and gp91
phox were
determined by quantitative RT-PCR. Briefly, 0.4–0.8 mg total
RNA was reverse transcribed using random hexamer primers and
the Superscript III First Strand cDNA system for RT-PCR
(Invitrogen) and the resulting cDNA was brought to 40 mL with
water. RT-PCR was carried out on a LightCycler instrument
(Roche Diagnostics, Indianapolis, IN) using the LightCycler
FastStart DNA Master SYBR Green kit (Roche Diagnostics).
Duplicate 20 mL PCR reactions contained 2 mL cDNA, 1X master
mix, 3 mM MgCl2 and 0.5 mM each primer for Ncf1 and Ncf2;
3 mM MgCl2 and 0.25 mM each primer for gp91
phox; and 4 mM
MgCl2 and 0.5 mM each primer for the house keeping gene Actb.
PCR primer sequences were as follows (all 59-39): Ncf1 forward –
GAGCCGCTGAGAGTCGCCAG; Ncf1-reverse – CCACGTC-
TCCGGTTGCCACG; Ncf2-forward – CCTCAGTCGCAGC-
CCCAGGA; Ncf2-reverse – GCCAAGCCGCGTCTCCATGA;
gp91
phox-forward - CCGGGATTGGAGTCACGCCC; gp91
phox-
reverse – AGGCATGCGTGTCCCTGCAC; ActB-forward -
AGCACAGCTTCTTTGCAGCTCCTTC; ActB-reverse - CT-
GGGCCTCGTCACCCACAT. The cycling conditions were 95u
for 10 minutes followed by 50 cycles of 95u for 2 seconds, 64u (65u
for Ncf2) for 2 seconds and 72u for 2 seconds and a single
fluorescence acquisition. The purity of the PCR products was
confirmed by melting analysis: samples were heated to 95u then
immediately brought to 65u for 15 seconds followed by heating to
95u at 0.1u per second with continuous fluorescence acquisition.
Ncf1, Ncf2, and gp91
phox values were normalized to those of Actb and
expressed relative to flow sorted but untreated cells at day 0 as
described in ref [29]. Amplification efficiencies for each primer
pair were greater than 95%.
Measurement of intracellular ROS
Intracellular ROS was measured by flow cytometry with 5-(and-
6)-chloromethyl-29,79-dichlorodihydrofluorescein diacetate, acetyl
ester (DCFDA; Invitrogen). Briefly, samples were stimulated in the
Figure 1. Outline of strategy for performing in vitro suppression assays to measure Treg suppression of Teff. Treg and Teff subsets
were isolated from mouse spleens and evaluated by flow cytometry prior to co-plating. The exact number of CD4+FOXP3- cells co-purifying with
Tregs (usually 10–15%; see arrow) was taken into consideration for plating so that the final CD4+FOXP3+ Treg:CD4+FOXP3- Teff ratio was exactly 1:1
(or 2:1 or 1:2 as indicated). The low and consistent number of contaminating CD4- cells in the isolates was not considered in the ratio and are not
shown in the dot plots. Prior to co-plating, the Teff subset was labeled with CFSE. The Treg:Teff mixtures were then added together to round bottom
96 well plates and stimulated with anti-CD3/CD28 coated beads at a bead:cell ratio of 1:1, in triplicate, for three days. Percent suppression was
calculated by comparing the proliferation of Teffs co-plated with Tregs to Teffs plated in the same conditions without Tregs.
doi:10.1371/journal.pone.0016013.g001
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the CD3/CD28 beads and resuspended in PBS with 2 mM
DCFDA. Each sample was then incubated with DCFDA for
exactly 15 minutes at 37uC. DCFDA fluorescence was then
immediately assessed by flow cytometry.
Statistics
Pairwise statistic analysis using the Student’s t-test was
performed using GraphPad Prism version 5.0 (GraphPad
Software, San Diego, CA).
Results
Thiol-bearing antioxidants and NADPH oxidase inhibitors
block or reduce direct Treg mediated suppression of
CD4+ effector T cells
In order to assess the potential contribution of ROS to Treg
suppression of Teffs we performed conventional Treg suppression
assays, using wild type cells and a 1:1 ratio of Tregs to Teffs, in the
presence of the antioxidant NAC to block ROS. Surprisingly, we
found that it completely prevented Treg-mediated suppression
(Figure 2A). Identical control assays performed in the absence of
NAC confirmed that the Tregs were suppressive, typically
generating approximately 60% suppression of Teff proliferation
when compared to Teffs cultured alone.
We next performed dose response experiments using varying
ratios of Tregs to Teffs (1:2, 1:1 and 2:1) and increasing doses of
NAC (0, 0.01 mM, 0.1 mM and 1 mM) in suppression assays
(Figure 2B). In the absence of NAC, suppression of Teffs
increased with increasing Treg:Teff ratios. The lowest concentra-
tion of NAC (0.01 mM) had no effect on suppression at any ratio.
At a concentration of 0.1 mM, NAC treatment resulted in
significantly reduced suppression at 1:1 (p=0.01) and 2:1
(p=0.01) ratios of Tregs:Teff. The highest NAC concentration
(1 mM) resulted in essentially absent suppression (p=0.08 for 1:2
ratio; p=0.002 at 1:1 ratio and p,0.001 at 2:1 ratio). These
studies indicate that a NAC concentration $0.1 mM in the
extracellular milieu is sufficient to inhibit or block suppression.
To assess the specificity of the findings, we performed
suppression assays in the presence of another thiol-bearing
antioxidant compound, 2-ME (Figure 3A/B) and found that 2-
ME augmented proliferation and completely blocked suppres-
sion. In order to assess whether or not the observed effects of
antioxidants could be duplicated by inhibiting the production of
intracellular oxidants by NADPH oxidase, we performed
suppression assays in the presence of NADPH oxidase inhibitors
VAS-2870 and diphenyleneiodonium and found that at very low
concentrations (100 nM and 10 nM, respectively) there was a
significant decrease in suppression (Figure 3A/B). However, in
contrast to NAC and 2-ME, neither of the two inhibitors had
any effect on augmenting the proliferation of Teffs alone
(Figure 3A).
Suppression by Tregs is partially dependent on TGFb and
n-acetylcysteine can overcome the suppressive effect of
exogenous TGFb1 on proliferation of isolated CD4+
effector T cells
In order to investigate the mechanism by which NAC
overcomes the suppressive function of Tregs, it was necessary to
identify the suppressive mediator or factor in the assay. We
suspected, based on previous findings, that the effect could be at
least be partly attributable to TGFb. Therefore, we performed
suppression assays in the presence of a TGFb neutralizing
antibody, or isotype control (Figure 4A). As before, suppression
assays were performed at a 1:1 ratio of Tregs: Teffs. Our
observations confirmed the findings of others [4] and showed that
neutralization of TGFb partially but incompletely blocked
suppression. This effect increased with increasing concentrations
of neutralizing antibody but was completely absent with a
nonspecific isotype control antibody, thus confirming the specific-
ity. We next sought to determine whether or not the presence of
NAC was sufficient to overcome the suppressive effects of
exogenous TGFb on the proliferation of CD3/CD28 stimulated
Teff, in the absence of Tregs. We found that 10 ng/mL TGFb
resulted in a significant decrease in the proliferation of Teff but
proliferation was restored by the addition of 1 mM NAC
(Figure 4B).
TGFb augments intracellular ROS production in CD3/
CD28 stimulated wild type but not Ncf1-deficient Teff
Because we had identified TGFb as an important factor for the
Treg-mediated suppression observed in our in vitro assays, and
because suppression by Tregs and the suppressive effects of
exogenously added TGFb were both reversible by the antioxidant
NAC, we were interested in determining intracellular ROS levels
in TGFb treated Teffs. To perform these experiments we utilized
wild type (WT) Teffs and Teffs isolated from Ncf1-deficient mice
that are unable to produce ROS via NADPH oxidase. The Ncf1
(p47
phox) gene encodes a component of the NADPH oxidase
complex that is required for sustained ROS production in T cells
in response to TCR triggering [21]. Ncf1-deficient mice have a
syndrome similar to a human disorder arising from Ncf1 mutations
(chronic granulomatous disease; CGD) that can be attributed
primarily to a lack of effective antimicrobial killing due to absence
of NADPH oxidase function in phagocytes [30]. However, they
also suffer from T cell mediated autoimmune arthritis [31] and
therefore also mimic some of the associated autoimmune
manifestations of human CGD.
We evaluated intracellular ROS in samples subjected to CD3/
CD28 stimulation in the presence of increasing concentrations of
TGFb. We also included control cells treated with L-buthionine
sulfoximine (added to experiments with WT Teff only), an
irreversible inhibitor of gamma-glutamylcysteine synthetase that
depletes intracellular glutathione by blocking its synthesis and thus
neutralizes the endogenous cellular antioxidant capacity. We
assessed intracellular ROS with the cell permeable indicator dye
DCFDA, an agent that fluoresces when oxidized and can be
measured by flow cytometry in its oxidized state. We found that
exogenous TGFb resulted in augmented intracellular ROS in WT
(Figure 5A) but not Ncf1-deficient Teffs (Figure 5B) versus that
seen with CD3/CD28 stimulation without TGFb. However, both
groups exhibited similar increases in ROS in response to CD3/
CD28 triggering alone and this suggests that sources of ROS other
than NADPH oxidase are available during prolonged TCR
signaling.
We next evaluated the ability of exogenous TGFb to suppress
proliferation of WT and Ncf1-deficient Teffs and found that there
was a significant dose dependent reduction in proliferation of WT
Teffs in response to TGFb (Figure 5C). Ncf1-deficient Teffs also
demonstrated reduced proliferation in the presence of TGFb but
there was no dose dependence and the reduction in proliferation
was significantly less than that observed in WT cells. Together, the
data indicate that Ncf1 is required for the TGFb mediated
augmentation of ROS. Furthermore, a lack of Ncf1 results in
blunted, though not absent, suppression of proliferation in
response to TGFb.
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PLoS ONE | www.plosone.org 5 January 2011 | Volume 6 | Issue 1 | e16013Figure 3. 2-mercaptoethanol and inhibitors of NADPH oxidase (VAS-2870 and DPI) block or reduce direct Treg-mediated
suppression of Teffs. Suppression assays were performed as outlined in the presence of 2-mercaptoethanol (2-ME) or the inhibitors of NADPH
oxidase, VAS-2870 or diphenyleneiodonium (DPI) at the indicated concentrations, or DMSO alone as a solvent only control, or without any added
agents as a positive suppression control. Panel (A) shows representative CFSE data from a single experimental trial. Panel (B) shows a compilation of
all data from three separate experiments, each performed in triplicate, and each generating similar results (NS – not significant, ** p#0.01).
doi:10.1371/journal.pone.0016013.g003
Figure 2. The antioxidant n-acetylcysteine (NAC) blocks direct Treg mediated suppression of Teffs in a dose dependent fashion.
Panel (A) shows the proliferation of CD3/CD28 stimulated Teffs (CFSE labeled) plated alone (white bars) or Teff plated at a 1:1 ratio with Tregs
(patterned bars) for 3 days, with and without 1 mM NAC. Data showing flow cytometric evaluation of CFSE staining with the calculated suppression
(%) is shown at right. This data is representative of that seen in more than 3 experiments. Panel (B) shows Treg-mediated suppression of Teff under
conditions of CD3/CD28 stimulation for three days in increasing concentrations of NAC (0.01 mM, 0.1 mM and 1 mM) with increasing Treg (labeled Tr
in figure) to Teff ratios of 1:2, 1:1 and 2:1. The data represents a compilation of data from three identical experiments each performed in triplicate and
each yielding similar findings.
doi:10.1371/journal.pone.0016013.g002
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Ncf1 mRNA expression but not Ncf2 or gp91
phox
Given the fact that we had noted a significant augmentation of
intracellular ROS in the presence of TGFb in WT Teff, we
wondered if this effect was due to increased expression of
components of the NADPH oxidase complex, Ncf1, Ncf2 or
gp91
phox. To evaluate this possibility, Teffs were isolated by flow
cytometric sorting of CD4+CD25- splenic T cells and stimulated
with CD3/CD28 beads with and without TGFb (10 ng/mL) for 1
and 2 days. Results demonstrated a marked increase in relative
expression of Ncf1 but not Ncf2 or gp91
phox in stimulated cells
(Figure 6). Samples stimulated with and without TGFb
demonstrated no significant differences in expression indicating
that the observed augmentation of ROS by TGFb was not due to
Figure 4. Suppression by Tregs is partially dependent on TGFband the suppressive effects of exogenous TGFb on Teff proliferation
can be overcome with NAC. (A) Suppression assays were performed as outlined with a 1:1 ratio of Tregs:Teff with and without TGFb neutralizing
antibodies at the indicated concentration, or nonspecific isotype control antibodies (IgG1), and anti-CD3/CD28 beads for 3 days. Similar results were
obtained in at least three identical experiments, each performed in triplicate. The data shown represents a compilation of all of these experiments. (B)
Purified, CFSE-labeled Teffs, without Tregs, were stimulated in the indicated conditions for 4 days with and without the addition of TGFb (10 ng/mL)
and NAC (1 mM). Proliferation was measured by flow cytometric evaluation of CFSE staining. The data shown is representative of three identical
experiments (NS – not significant, ** p#0.01).
doi:10.1371/journal.pone.0016013.g004
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PLoS ONE | www.plosone.org 8 January 2011 | Volume 6 | Issue 1 | e16013enhanced gene expression. However, the observation that
stimulation in general results in a marked increase in Ncf1
expression may indicate that it has a wider role in TCR/CD28
signaling than has previously been thought.
Ncf1
2/2 Tregs are poorly suppressive to Ncf1
2/2 Teff and
there is incomplete reconstitution of suppression of wild
type Teff by Ncf1
2/2 Tregs and of Ncf1
2/2 Teff by wild
type Tregs
Because we observed that NAC, 2-ME and NADPH oxidase
inhibitors all resulted in varying degrees of inhibited suppression,
and since exogenous TGFb was less effective at suppressing the
proliferation of Ncf1-deficient Teffs, we next evaluated suppres-
sion using Tregs and Teffs isolated from Ncf1
2/2 mice. First, we
evaluated the total number of splenic Tregs in these mice to assess
for quantitative differences, due to differential NADPH oxidase
function in vivo, and found none (Figure 7A). Subsequently, we
performed suppression assays using Ncf
2/2 Tregs (Tregs
Ncf12/2)
as suppressor cells along with Ncf
2/2 Teffs (Teffs
Ncf12/2). We
found markedly reduced overall suppression at Treg:Teff ratios of
both 1:1 and 2:1 (Figure 7B) as compared to that seen in identical
assays using wild type Tregs and Teffs. A 1:1 ratio yielded a mean
suppression of 11.7% (64.04) and a 2:1 ratio yielded a mean
Figure 6. Expression of Ncf1, Ncf2 and gp91
phox in CD3/CD28 stimulated Teffs with and without TGFb. Teffs were purified from WT C57BL/
6 mouse spleen suspensions by flow cytometric sorting (.98% pure CD4+CD25- cells after sorting) then subjected to stimulation with CD3/CD28
beads with and without exogenous TGFb (10 ng/mL) for 1 and 2 days. Total RNA was isolated from freshly sorted but unstimulated cells (Day 0) and
from stimulated cells at day 1 and day 2. mRNA expression of three components of the NADPH oxidase complex, Ncf1, Ncf2 and gp91
phox, was
measured by RT-PCR and normalized to expression of the housekeeping gene, b-actin. The data is graphed as fold-change in expression relative to
Day 0 (arbitrarily defined as a relative expression of 1). The figure represents a compilation of data from three separate experiments.
doi:10.1371/journal.pone.0016013.g006
Figure 5. Treatment of Teffs with TGFb results in a dose dependent elevation of intracellular oxidants. (A) Isolated, unlabeled Teffs,
without Tregs, were cultured in the indicated conditions with exogenous TGFb (2 and 10 ng/mL) or with the gamma-glutamylcysteine synthetase
inhibitor buthionine sulfoximine (BSO; 1 mM) to deplete intracellular glutathione, and anti-CD3/CD28 beads for 24 hours. Subsequently, samples
were labeled with the fluorescent, oxidant sensitive cell permeable indicator dye 5-(and-6)-chloromethyl-29,79-dichlorodihydrofluorescein diacetate,
acetyl ester (DCFDA), each for exactly 15 minutes then immediately subjected to flow cytometric evaluation of DCFDA fluorescence. The data shown
represents mean fluorescence intensity of DCFDA and is representative of three identical experiments, each performed in triplicate and each yielding
similar results. (B) A similar experiment was performed using Teffs isolated from Ncf1-deficient mice. (C) CFSE labeled WT or Ncf1-deficient Teffs were
stimulated as indicated for four days with anti-CD3/CD28 beads with and without exogenous TGFb (2 and 10 ng/mL) then evaluated for proliferation
by flow cytometric quantification of CFSE staining. The data shown represents the % reduction in proliferation of TGFb treated Teffs vs untreated Teff
samples and is representative of three identical experiments (NS – not significant, * p,0.05, **p#0.01).
doi:10.1371/journal.pone.0016013.g005
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of approximately 50% for a 1:1 ratio using wild type cells and
.60% for a 2:1 ratio with wild type cells (see Figure 2B).
Interestingly, the addition of TGFb neutralizing antibodies still
had a small but significant effect on blocking suppression
(suppression =2.3% 61.2 for a 1:1 ratio of Tregs:Teff with
30 mg/mL anti-TGFb), essentially eliminating what residual
suppression remained (p=0.02 for the comparison of a 1:1 ratio
with and without anti-TGFb). These results show that the absence
of Ncf1, and by extension the lack of functional NADPH oxidase,
results in markedly reduced, but not completely absent, direct
Treg suppression of Teffs.
In light of the finding of very poor suppression of Teffs
Ncf12/2
by Tregs
Ncf12/2 we wondered whether this effect was due to a
lack of Ncf1 in the Teffs, as we had initially hypothesized, or
whether it could be attributable to both T cell subsets. To assess
this, we performed suppression assays using wild type Tregs
(Tregs
WT) co-cultured with CFSE labeled Teffs
Ncf12/2 and
Tregs
Ncf12/2 co-cultured with wild type CFSE-labeled Teffs
(Teffs
WT). In this way, the ramifications of the lack of NADPH
oxidase could be isolated to either Tregs or Teffs. Suppression
assays performed in this way are shown in Figure 8. Conditions
with Tregs
Ncf12/2 co-cultured with Teffs
WT and with Tregs
WT co-
cultured with Teffs
Ncf12/2 showed significantly reduced suppres-
sion as compared to control assays with Teffs
WT and Tregs
WT
(p,0.002 for both comparisons). Conditions with Tregs
Ncf12/2
and Teffs
WT demonstrated slightly higher suppression than control
samples with Tregs
Ncf12/2 and Teffs
Ncf12/2 but this was not
significant (p=0.11). Assays with Tregs
WT and Teffs
Ncf12/2
demonstrated significantly higher levels of suppression than
Tregs
Ncf12/2 and Teffs
Ncf12/2 (p=0.003). Taken together, these
results indicate that Ncf1 expression, and by extension NADPH
oxidase function, is necessary in both Tregs and Teffs for optimum
suppression to occur.
Discussion
The process by which Tregs suppress the activation and
proliferation of effector T cells remains relatively poorly
understood in spite of intense efforts to understand it. A ROS
mediated mechanism to potentiate suppression by Tregs has not
been explored. However, there is evidence that NADPH oxidase
derived ROS play a general role in immunosuppression. One of
the strongest genetic associations with autoimmune arthritis in
animal models of the disease is the gene Ncf1 that, when deleted,
leads to low ROS production and autoimmunity [32,33]. A second
observation that supports an immunosuppressive role for ROS is
found in the inherited syndrome CGD. CGD patients lack
NADPH oxidase function, suffer from impaired immunity due to
the inability to mount a phagocyte oxidative burst and have high
rates of bacterial infections. However, affected individuals also
suffer from increased rates of autoimmune disease including
Figure 8. There is significant but incomplete reconstitution of suppression of Ncf1
2/2 Teffs by wild type Tregs. Suppression assays
were performed with mixtures (all at a 1:1 ratio) of wild type Tregs and Teffs (labeled Tr
WT and Teff
WT respectively) and Ncf1
2/2 Tregs and Teffs
(labeled Tr
Ncf1- and Teff
Ncf1- respectively) as indicated in the figure. As above, samples were stimulated for three days with anti-CD3/CD28 beads and
suppression was calculated by measuring Teff proliferation when plated alone and when plated with Tregs. The data shown is a compilation of at
least three identical experiments, each performed in triplicate and each yielding similar results (NS – not significant, **p#0.01).
doi:10.1371/journal.pone.0016013.g008
Figure 7. Suppression of Ncf1
2/2 Teffs by Ncf1
2/2 Tregs is markedly decreased. (A) Tregs were quantified in total spleen cell suspensions
from WT C57BL/6 mice (Tr
WT) and from Ncf1-deficient mice (Tr
Ncf12/2) by flow cytometric evaluation of CD4 and FOXP3 expression. CD4+FOXP3+
Tregs are shown gated with the percentage of Tregs in total spleen cells and the percentage of Tregs among only CD4+ T cells in parentheses. This
data is representative of that observed from three WT and three Ncf1
2/2 mice. (B) Suppression assays were performed using Ncf1
2/2 Tregs and
Ncf1
2/2 Teffs co-cultured at the indicated ratios (1:1 and 2:1) along with Ncf1
2/2 Teffs alone as controls. TGFb neutralizing antibodies (30 mg/mL)
were added to one set of samples as indicated. Samples were stimulated for 3 days with CD3/CD28 beads. The data shows proliferation of Ncf1
2/2
Teffs cultured alone and Ncf1
2/2 Teffs co-cultured with Ncf1
2/2 Tregs in suppression assays. CFSE staining data is shown at right along with the
calculated suppression for this representative result (%). The data shown is representative of at least 3 identical experiments.
doi:10.1371/journal.pone.0016013.g007
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In addition, chronic colitis is a major cause of morbidity in the
majority of patients [35]. The etiology of CGD related
autoimmunity remains unexplained.
Thymus-derived Tregs are markedly less sensitive than effector
T cells to oxidant stress induced cell death [36] and this perhaps
suggests a particular role for ROS in Treg function and
physiology. Glutaredoxin, encoding an enzyme involved in redox
regulation and glutathione-mediated oxidant defense, is specifi-
cally upregulated by the Treg-specific transcription factor FOXP3
[37]. There is evidence that Tregs may indirectly suppress the
proliferation of Teffs by inhibiting the secretion of glutathione/
cysteine into the microenvironment by dendritic cells which
otherwise would create an extracellular redox potential that
facilitates T cell proliferation [18]. Furthermore, a recent study
showed that Tregs modulate glutathione metabolism in Teffs via a
cell-contact and antigen-dependent, but not antigen-specific,
mechanism during suppression [38]. The mechanism for this
was not identified but could potentially involve NADPH oxidase.
Macrophages have also been shown to suppress T cell activation in
vitro and in vivo through ROS [39] and, recent data demonstrates
that macrophages induce Tregs via a ROS dependent pathway
that can be blocked by the NADPH oxidase inhibitor apocynin
[40]. However, the potential role of TGFb was not addressed in
the latter study. This finding, considered together with the
observation that ROS is augmented by TGFb, highlights the
possibility that the induction of Tregs in the periphery by TGFb
could be related to ROS. However, in the case of thymus derived
natural Tregs, presumably comprising the majority of spleen
Tregs, our data demonstrates no quantitative differences in
animals lacking NADPH oxidase function.
Our findings showed that thiol-bearing antioxidants and
NADPH oxidase inhibitors had an antagonistic effect on Treg-
mediated suppression, supporting the hypothesis that NADPH
oxidase derived ROS is important in this process. Furthermore, a
lack of Ncf1 in both Tregs and Teffs was also associated with
markedly reduced suppression that was partially but significantly
reconstituted in assays with wild type Tregs suppressing Ncf1-
deficient Teff. Taken together, our data indicate that NADPH
oxidase function in both Tregs and in targeted effector CD4+ T
cells is necessary for suppression. We hypothesize that these effects
are mediated only partially by TGFb receptor signaling in Teffs.
Previous findings suggest that T cell derived ROS, produced in
response to CD3/CD28 triggering, is necessary for the activation
of latent TGFb [23] and this could possibly explain some of the
findings that we have observed. However, the observation that
NAC can overcome the suppressive effects of exogenous, active
TGFb shows that this is not a completely sufficient explanation.
Furthermore, TGFb neutralization still results in a decrease in the
residual suppression seen with Tregs and Teff, both lacking Ncf1.
One explanation would be that TGFb conditions Teffs to respond
to Tregs via NADP oxidase dependent and non-dependent
pathways that are necessary but not fully sufficient for suppression
to occur. This remains to be seen.
In additional to its apparent importance in Teffs, we also show
that NADPH oxidase function in Tregs themselves is a major
contributor to the observed suppression. The means by which this
occurs are unclear but perhaps Treg derived ROS could serve to
alter the redox potential of the microenvironment in a similar
fashion to ROS produced by Teff themselves. Furthermore, close
apposition of Tregs and Teff could facilitate this process and this
may be an additional explanation for the apparently cell contact
dependent suppression observed in many in vitro studies. Such a
mechanism could possibly contribute to the depletion of cysteine
and glutathione that has been recently observed in Teffs
undergoing suppression by Tregs [38].
The finding that NADPH oxidase function in Tregs is necessary
for optimum suppression serves as a possible explanation for why
TGFb neutralizing antibodies are only partially effective in our
experiments at inhibiting suppression. Partial blockade of
suppression in the setting of TGFb neutralization has been
observed previously but complete blockade was achieved in the
presence of both TGFb and CTLA-4 neutralizing antibodies [4].
However, Tregs from CTLA-4 knockout mice still display normal
suppressive function in vitro [41]. Thus no single mechanism or
pathway has been implicated as being indispensible to the
suppressive function of Tregs. We observed that TGFb neutral-
izing antibodies still had an effect on suppression in assays with
Tregs and Teff both lacking Ncf1. Furthermore, exogenous TGFb
was still suppressive to Ncf1-deficient Teffs. This indicates that
TGFb has suppressive effects in the absence of NADPH oxidase
function. Ncf1
2/2 mice display features of increased autoimmunity
[31,33,42] and we have shown that their Tregs are very poorly
suppressive in vitro. However, these animals certainly do not suffer
from the severity of autoimmunity that is seen in mice with foxp3
mutations and a complete lack of Tregs [43] or in mice that have
been depleted of Tregs [44,45,46]. Our observations indicate that
there is some remaining suppressive function, apparently related to
TGFb, that is displayed during the interaction of Ncf1
2/2 Tregs
and Ncf1
2/2 Teff and perhaps this may serve as an explanation for
mild to moderate degree of autoimmunity in Ncf1
2/2 mice. The
reduced Treg function in these animals may simply predispose to
the development of autoimmunity, especially in response to certain
stimuli such as those used to experimentally induce arthritis [33].
An apparent predisposition to autoimmunity in Ncf1
2/2 mice is
similar to the findings in human CGD patients.
In summary, our studies show that suppression by mouse Tregs
can be blocked, in vitro, by thiol-bearing antioxidants, NADPH
oxidase inhibitors or by genetic deficiency in the NADPH oxidase
component Ncf1, supporting an important role for oxidants and
the cellular redox state in Treg-mediated suppression. Further-
more, NADPH oxidase function in both Tregs and Teffs appears to
be a requirement for optimum suppression in a pathway that
partially involves TGFb. We hypothesize that redox modulation,
whether by MDSC, dendritic cells or Tregs, may be a central
theme in the regulation of effector T cell function by regulatory
immune subsets in a variety of circumstances. Mechanisms of
ROS production may represent an attractive target for the
development of new immune modulating therapies.
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